Journal
CURRENT TREATMENT OPTIONS IN NEUROLOGY
Volume 15, Issue 2, Pages 125-149Publisher
CURRENT MEDICINE GROUP
DOI: 10.1007/s11940-012-0217-2
Keywords
Hemorrhagic transformation; Parenchymal hemorrhage; Hemorrhagic infarction; Thrombolytics; Symptomatic hemorrhage; Asymptomatic hemorrhage; Management of HT; Treatment; Clinical predictors; Imaging; Ferritin; Blood pressure; Hyperglycemia
Categories
Funding
- Remedy Pharmaceuticals
Ask authors/readers for more resources
Hemorrhagic Transformation (HT) has been well recognized as a common cause of hemorrhage in ischemic stroke patients. Though this complication may occur independently, it has been particularly dreaded in the post rTPA patient and thus has been the focus for analysis of multiple thrombolytic trials. This review examines the effect of different clinical predictors for hemorrhagic transformation and summarizes pertinent clinical trials, with a focus on the rational for design of future studies. Although currently there are no official guidelines for the acute management of HT per se, based upon review of the literature regarding pertinent clinical predictors herein, an innovative approach for the acute management of the HT patient is proposed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available